Delivery Order SPE2DR25D6028-SPE2DR26FASDU
Award Date 12/1/25
Potential Completion Date 12/29/25
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $12,305.83 to AmerisourceBergen Drug Corp for Adalimumab 2PPN 2S on December 10, 2025, with an ultimate completion date of January 8, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting...
- The Department of Defense's Medical Supply Chain awarded a delivery order valued at $7,553.00 to AmerisourceBergen Drug Corp for Adalimumab 2PPN 2S on August 22, 2025, with completion targeted for August 25, 2025. This competitive award, utilizing firm fixed price terms, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The vendor, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,946.52 to Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company based in Conshohocken, Pennsylvania. The contract is for the supply of the specialty drug Adalimumab-FKJP (CF) Pen 40 MGs. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
- The Defense Logistics Agency awarded a delivery order valued at $2,776.98 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) Pen 40 mg/0.4 mL on November 28, 2025, with completion scheduled for December 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $1,510.60 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on August 4, 2025, with an ultimate completion date of August 5, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded through open procurement. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a $7,091.62 delivery order to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on November 25, 2025, with an ultimate completion date of November 26, 2025. This non-set-aside contract employs firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency awarded a $7,249.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL pharmaceutical supplies on December 3, 2025, with completion scheduled for December 4, 2025. This non-set-aside competitive award was fulfilled from the vendor's place of performance in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader indefinite delivery contract vehicle with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $7,989.80 to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) Pen 40 mg/0.4 mL pharmaceutical supply. This non-competitive delivery order carries a firm fixed price and was issued on July 8, 2025, with an ultimate completion date of July 9, 2025. The pharmaceutical product will be sourced and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $3,303.86 delivery order to AmerisourceBergen Drug Corp for HUMIRA (Adalimumab) CF Pen 40 mg/0.4 mL pharmaceutical products on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes a delivery order mechanism, indicating it operates under a larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,979.90 to AmerisourceBergen Drug Corp for HUMIRA (adalimumab) pen 40 mg/0.4 mL units, with an ultimate completion date of December 1, 2025. This non-competitive delivery order represents a firm fixed-price transaction under the company's existing indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be performed at the vendor's facility in Conshohocken, Pennsylvania, where...